CN112914109B - Preparation method and application of peptide nano-selenium - Google Patents
Preparation method and application of peptide nano-selenium Download PDFInfo
- Publication number
- CN112914109B CN112914109B CN202110160008.4A CN202110160008A CN112914109B CN 112914109 B CN112914109 B CN 112914109B CN 202110160008 A CN202110160008 A CN 202110160008A CN 112914109 B CN112914109 B CN 112914109B
- Authority
- CN
- China
- Prior art keywords
- selenium
- preparation
- acid
- ore
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 133
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 131
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 104
- 150000007524 organic acids Chemical class 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 13
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 239000003085 diluting agent Substances 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- 102000005741 Metalloproteases Human genes 0.000 claims description 2
- 108010006035 Metalloproteases Proteins 0.000 claims description 2
- 101710097834 Thiol protease Proteins 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003566 thiocarboxylic acids Chemical class 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- 230000007071 enzymatic hydrolysis Effects 0.000 claims 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- -1 selenium ions Chemical class 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 239000003054 catalyst Substances 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- SDWSBMKMILEYGK-VHEBQXMUSA-N (e)-19-sulfooxynonadec-2-ene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C\C(C(O)=O)=C(C(O)=O)\CCCCCCCCCCCCCCCCOS(O)(=O)=O SDWSBMKMILEYGK-VHEBQXMUSA-N 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940091258 selenium supplement Drugs 0.000 description 111
- 239000000243 solution Substances 0.000 description 26
- 241000196324 Embryophyta Species 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 17
- 244000105624 Arachis hypogaea Species 0.000 description 15
- 235000020232 peanut Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 235000017060 Arachis glabrata Nutrition 0.000 description 6
- 235000010777 Arachis hypogaea Nutrition 0.000 description 6
- 235000018262 Arachis monticola Nutrition 0.000 description 6
- 206010025538 Malignant ascites Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 102000006587 Glutathione peroxidase Human genes 0.000 description 3
- 108700016172 Glutathione peroxidases Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000004452 decreased vision Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005274 electronic transitions Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a preparation method and application of peptide nano-selenium, belonging to the technical field of deep processing of foods. A process for preparing nano-Se peptide includes reaction between Se ore and organic acid under electromagnetic catalysis, and culturing plant in the culture liquid. According to the invention, the reaction of the selenium ore and the organic acid is electromagnetically catalyzed, so that selenium in the selenium ore can be converted into free selenium ions and further converted into selenate ions, and therefore, the utilization rate of plants on selenium in the ore can be improved and further converted into peptide nano selenium; the process does not need to add a chemical catalyst, and accords with the concept of green chemistry; the culture solution prepared from selenium ore is used for selenium-rich culture of plants, the culture period is short, and the yield of peptide nano selenium is improved.
Description
Technical Field
The invention belongs to the field of deep processing of foods, and particularly relates to a preparation method and application of peptide nano-selenium.
Background
The human body is composed of more than 60 elements. According to the different contents of elements in human body, it can be divided into two categories of macroelements and microelements. At present, there are 18 kinds of essential trace elements that have been confirmed to be related to human health and life, i.e., iron, copper, zinc, cobalt, manganese, chromium, selenium, iodine, nickel, fluorine, molybdenum, vanadium, tin, silicon, strontium, boron, rubidium, arsenic, etc. Each of these trace elements has its own specific physiological function. Although they are present in very small amounts in humans, they are essential for maintaining some crucial metabolism in humans. Once these essential trace elements are absent, the human body can become ill and even life-threatening.
Selenium is used as a trace element and has multiple effects on human health. The method comprises the following steps:
and (3) regulating immunity: studies have shown that selenium can affect the immune system (including cellular, humoral, and non-specific immunity); for tumor patients, the decline of immune function and the deterioration of disease are vicious cycles, and the radiation therapy can also cause damage to the immune system; therefore, clinically, a proper amount of selenium is often supplemented to the tumor patients to improve the immunity of the organism and prevent and resist cancers.
Antioxidation: the main existing forms of selenium in human body are selenase and selenoprotein, wherein the selenium in glutathione peroxidase accounts for about 1/3 of the total selenium in human body. Glutathione peroxidase reduces peroxides harmful to the human body, thereby assisting in scavenging free radicals and protecting biofilms from oxidative damage by peroxides.
Inhibiting tumor growth: research finds that selenium can promote the growth of anti-tumor angiogenesis inhibiting factors and form an anti-tumor angiogenesis environment, so that the formation and development of tumor angiogenesis are inhibited, and a nutrition supply channel of tumor cells is cut off; under the same condition, selenium has certain protection effect on normal cells, and the phenomenon is more prominent under the condition of oxygen deficiency. Similar effects were also found in laboratory cell cultures. Relatively speaking, the probability of suffering from tumor is higher for the selenium-deficient people; the patients with selenium-deficient tumors are more likely to suffer from adverse phenomena affecting life cycle, such as lesion metastasis, multiple tumors, tumor deterioration, and the like.
Protecting the liver: the effect of selenium in liver protection is proved by a plurality of researchers, researchers find that the incidence rate of hepatitis patients can be reduced by 56% by selenium supplement, the recovery of the patients is promoted, and the researchers find that transaminase of the alcoholic liver patients can be recovered to be normal by selenium supplement treatment, the serum cholesterol content can be reduced, the low-density lipoprotein content can be reduced, the high-density lipoprotein content can be increased, and the effect of treating the fatty liver can be achieved. In the treatment of liver diseases, selenium and liver treatment medicines with toxic and side effects have good synergistic effect when taken together. The action mechanism of selenium for protecting the liver is as follows: the antioxidant effect of glutathione peroxidase and the promoting effect of selenium on human body immunity.
Antiviral ability: statistical data indicate that when a human body is short of selenium, the risk of infecting highly pathogenic viral diseases is obviously increased. Such as coxsackie virus, common cold virus, aids virus, ebola virus, smallpox virus, hepatitis virus, and even the novel coronavirus (COVID-19), are associated with selenium levels in patients.
In addition, selenium deficiency in humans can lead to cardiomyopathy, coronary heart disease, hypertension, diabetes, gastric disorders, decreased brain function (affecting the rate of metabolism of the brain 'neurotransmitter'), decreased vision, decreased thyroid function, and reduced male sexual function.
Therefore, it is very important to supplement selenium to the human body in a targeted manner, but not all of the selenium can be absorbed by the human body. Some selenium species can be absorbed by the human body, but have high toxicity. In contrast, organic selenium has a higher utilization than inorganic selenium, while having a lower toxicity than inorganic selenium. The method of natural selenium supplement is more beneficial to health than the method of taking inorganic selenium. However, in common edible crops, the content of organic selenium is low.
Disclosure of Invention
The present invention is directed to solving at least one of the problems of the prior art described above. Therefore, the invention provides a preparation method of peptide nano-selenium, which can enable plants to efficiently utilize selenium in ores and improve the content of the peptide nano-selenium in the plants.
The invention also provides the application of the peptide nano-selenium in the field of food and medicine preparation.
According to one aspect of the invention, the preparation method of the peptide nano-selenium is provided, which comprises the steps of reacting selenium ore with organic acid under electromagnetic catalysis, and taking a diluent of a system after reaction as a culture solution to culture plants.
According to a preferred embodiment of the invention, at least the following advantages are achieved:
(1) The selenium ore reacts with the organic acid under the electromagnetic catalysis, so that selenium in the selenium ore can be converted into free selenium ions and further converted into selenate ions, and therefore the utilization rate of plants to the selenium can be improved.
(2) The invention uses the diluent of the culture solution prepared by selenium ore to culture the selenium-rich of the plants, the culture period is short, and the yield of the peptide nano-selenium is improved.
(3) The preparation method of the peptide nano-selenium provided by the invention does not need to utilize a chemical catalyst, and is more in line with the concept of green chemistry.
(4) The content of the peptide nano selenium in the plant obtained by the method provided by the invention is as high as 340mg/kg.
In some embodiments of the present invention, the method for preparing peptide nano-selenium comprises the following steps:
s1, crushing the selenium ore to obtain selenium ore powder;
s2, adding the organic acid into the selenium ore powder, and performing electromagnetic catalytic reaction to obtain a selenium concentrated solution;
s3, taking a diluent of the selenium concentrated solution as a culture solution, and carrying out selenium-rich culture on the plants;
and S4, extracting nutrient substances of the plants obtained in the step S3, and carrying out enzymolysis to obtain the peptide nano selenium.
In some embodiments of the present invention, in step S1, the selenium ore powder has a particle size of 60 to 80 mesh.
The purpose of crushing the selenium ore is to increase the specific surface area of the selenium ore and improve the efficiency of the reaction in the step S2.
In some embodiments of the present invention, in step S2, the organic acid is at least one of carboxylic acid, sulfonic acid, sulfinic acid, and thiocarboxylic acid.
In some embodiments of the invention, the carboxylic acid is at least one of formic acid, acetic acid, octanoic acid, halogenated acids, hydroxy acids, keto acids, and amino acids.
In some embodiments of the invention, in step S2, the organic acid is purchased commercially without the addition of water-diluted concentrated acid.
In the step S2, some organic acids can participate in animal and plant metabolism and have obvious biological activity, so that the organic acids are used for preparing the culture solution and have no harm to the growth of plants and the individuals eating the plants.
In some embodiments of the present invention, in step S2, the mass ratio of the organic acid to the selenium ore powder is (2 to 50): 1.
the organic acid reacts with selenium in the selenium ore to generate selenate on one hand; another aspect is the effect of pH adjustment.
In some embodiments of the invention, step S2 is an electromagnetic catalytic reaction, the electromagnetic frequency being 0.3GHz to 300GHz.
In some embodiments of the invention, step S2 is an electromagnetic catalytic reaction, electromagnetic wavelength 10 -3 m~1m。
The electromagnetic catalytic reaction has the following functions: the high-frequency oscillation of the electromagnetic wave can accelerate the electronic transition of selenium in the selenium ore, and further convert the selenium in the selenium ore into ionic water-soluble selenium.
The organic acid has the following functions: reacting with ionic selenium generated by electromagnetic catalysis to generate stable and controllable selenate ions.
Under the weak acid environment, the plant utilization rate of the selenate ions is high, and the plants can utilize the selenate ions more quickly.
In some embodiments of the present invention, in step S2, the selenium concentration in the selenium concentrated solution is 20% to 45% by mass.
In some embodiments of the invention, in step S2, the selenium concentrate has a pH of 4.5 to 6.8.
In some embodiments of the present invention, in step S3, the dilution ratio of the diluted solution is 10 to 20 times, that is, each milliliter of selenium concentrated solution is diluted to 10 to 20ml with distilled water.
In some embodiments of the invention, in step S3, the pH in the culture solution is 4.5 to 6.8.
In some embodiments of the present invention, in step S3, the plant is at least one of common crops such as peanut, malt, corn, barley, soybean, and the like, vegetables such as cabbage, garlic, and the like, and fruit plants.
In some embodiments of the invention, in step S3, the selenium-enriched culture is performed for a period of 1 to 3 weeks.
In some embodiments of the invention, in step S3, the selenium-enriched culture is performed at a temperature of 20 ℃ to 40 ℃ under an illumination of 5 × 10 4 ~7×10 4 lx。
In some embodiments of the present invention, the plant or fruit cultured in step S3 may be sold without performing the step S4 according to the needs of the consumer.
In some embodiments of the invention, in step S4, the extracting comprises: cleaning and juicing the plants or fruits obtained in the step S3, adjusting the obtained juice to 40-60 ℃, adjusting the pH to 4.5-6.8, adding the complex enzyme, and standing for 12 hours under the condition of heat preservation; cooling to normal temperature, filtering to obtain filtrate, and obtaining the peptide nano selenium.
In some embodiments of the present invention, in step S4, the extraction subject may be the whole plant of the plant obtained in step S3 or a fruit part of the plant.
In some embodiments of the present invention, in step S4, the enzyme is at least one of thiol protease and metalloproteinase.
The peptide nano-selenium is applied to the field of food and medicine preparation.
In some embodiments of the present invention, the peptide nano-selenium can be directly eaten or can be combined with other ingredients to prepare foods or medicines for supplementing selenium to animals or human bodies.
Detailed Description
The idea of the invention and the resulting technical effects will be clearly and completely described below in connection with the embodiments, so that the objects, features and effects of the invention can be fully understood. It is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments, and other embodiments obtained by those skilled in the art without inventive efforts are within the protection scope of the present invention based on the embodiments of the present invention.
Example 1
The preparation method of the peptide nano-selenium comprises the following specific steps:
s1, crushing selenium ore powder to 80 meshes to obtain selenium ore powder;
s2, adding acetic acid into the selenium ore powder, wherein the mass of the acetic acid is 2 times that of the selenium ore powder;
s3, performing electromagnetic catalytic reaction on the system obtained in the step S2, wherein the frequency of the electromagnetic catalysis is 0.3GHz, the wavelength is 1m, and obtaining selenium concentrated solution with pH =6.8 after the reaction is completed;
s4, diluting the selenium concentrated solution obtained in the step S3 by 20 times, taking the diluted solution as a culture solution, and performing selenium-rich culture on the peanuts for 3 weeks, wherein before the selenium-rich culture, the peanut seeds are soaked in water for 24 hours at normal temperature;
and S5, extracting nutrient substances of the peanuts (100 whole plants) obtained in the step S4, and carrying out enzymolysis to obtain the peptide nano selenium.
Comparative example 1
The difference between the preparation of the peptide nano-selenium and the example 1 is that the specific process is as follows:
(1) Step S3 is not included, namely, the system obtained in step S2 is diluted by 20 times to be used as a culture solution, and the peanut is cultured for 3 weeks.
Comparative example 2
The comparative example prepares titanium nano-selenium, and the specific process is as follows:
s1, preparing Hoagland nutrient solution, wherein a specific formula is shown in a table 1;
s2, using the nutrient solution obtained in the step S1 as a culture solution, carrying out selenium-rich culture on the peanuts for 3 weeks, and soaking the peanut seeds in water for 24 hours at normal temperature before the selenium-rich culture;
and S3, extracting nutrient substances of the peanuts (100 whole plants) obtained in the step S4, and performing enzymolysis to obtain the peptide nano-selenium.
Table 1 hodgkin's nutrient solution formula.
The preparation method of the iron salt solution comprises the following steps: adding 2.78g of ferrous sulfate heptahydrate and 3.73g of disodium ethylene diamine tetraacetate into 500ml of distilled water;
the microelement solution is mixed water solution, and the solute concentration in the solution is 0.83mg/L potassium iodide, 6.2mg/L boric acid, 22.3mg/L manganese sulfate, 8.6mg/L zinc sulfate, 0.25mg/L sodium molybdate, 0.025mg/L copper sulfate and 0.025mg/L cobalt chloride.
Comparative example 3
The comparative example prepares the titanium nano-selenium, and the specific process comprises the following steps:
s1, crushing selenium ore to 80 meshes;
s2, uniformly mixing the selenium ore powder obtained in the step S1 with peat soil 1 in a mass ratio of;
s3, planting the peanut seeds soaked in water for 24 hours at normal temperature into the mixed system obtained in the step S2, watering with purified water, and planting for 3 weeks;
and S4, extracting nutrient substances of the peanuts (100 whole plants) obtained in the step S3, and carrying out enzymolysis to obtain the peptide nano-selenium.
Comparative example 4
The comparative example prepares the titanium nano-selenium, and the specific process comprises the following steps:
s1, preparing a culture solution with the mass concentration of 1% and the pH value of 6.8 by using sodium selenite (CAS: 10102-18-8) and acetic acid as raw materials;
s2, taking the selenium concentrated solution obtained in the step S1 as a culture solution, and performing selenium-rich culture on the peanuts for 3 weeks, wherein before the selenium-rich culture, the peanut seeds are soaked in water for 24 hours at normal temperature;
and S3, extracting nutrient substances of the peanuts (100 whole plants) obtained in the step S2, and carrying out enzymolysis to obtain the peptide nano-selenium.
Test examples
The experimental example tests the content of the peptide nano selenium in the peanut plants obtained in the examples and the comparative examples, and the cost for preparing the peptide nano selenium in the peanut plants obtained in the examples 1 and the comparative examples 4.
Wherein, the calculation of the content of the peptide nano selenium refers to the formula: content = mass of peptide nano selenium/mass of plant material used; the calculation results are shown in table 2.
In the examples and comparative examples, the testing of peptide nanoselenium was carried out with reference to the national standard document GB 5009.93-2017.
Table 2 content of peptide nanoseles in examples and comparative examples.
Description of the preferred embodiment | Example 1 | Comparative example 1 | Comparative example 2 | Comparative example 3 | Comparative example 4 |
Content (wt.) | 340mg/kg | 10mg/kg | 2mg/kg | 11mg/kg | 300mg/kg |
The cost accounting is shown in table 3.
Table 3 cost accounting for example 1 and comparative example 4.
The calculation method of the cost reduction comprises the following steps: the product of the unit price and the dosage of the material in the example 4 is subtracted by the product of the unit price and the dosage of the material in the example 1, and the difference is divided by the product of the unit price and the dosage of the material in the example 4.
In conclusion, the preparation method of the peptide nano-selenium provided by the application has high utilization rate of selenium in ores, and the content of the peptide nano-selenium in a single plant is as high as 340mg/kg; compared with the selenium-rich culture with sodium selenate culture nutrient solution, the cost is reduced by about 91 percent.
Application example
In the application example, the peptide nano selenium obtained in the examples and the comparative examples is applied to mice with malignant ascites to observe the treatment and recovery effects of the peptide nano selenium on the mice.
The modeling method comprises the following steps: mice were injected intraperitoneally with 0.1mL of EAC cells (cell number 1X 10) 6 One). And judging the modeling effect after six days.
Dividing the modeled mice with malignant ascites into 3 groups of 10 mice, wherein the control group is intraperitoneally injected with normal saline (9 mg/kg) every day; the standard group was given daily drug therapy (carboplatin, 9 mg/kg) to mice, and example 1 was injected daily with physiological saline (1 mg/mL,9 mg/kg) containing the corresponding peptide nanoselenium.
Mice were dissected 14 days after administration and tested for recovery of malignant ascites in mice in example 1, the standard group and the control group. The test results are shown in table 4.
Table 4 therapeutic effect of peptide nanoselenium on malignant ascites in mice.
Group of | Example 1 | Control group | Standard group |
Ascites volume ml | 2.1 | 22 | 1.6 |
The results show that the peptide nano-selenium prepared by the invention has excellent biological activity and obvious effect on the treatment of malignant ascites of mice. The embodiments of the present invention have been described in detail, but the present invention is not limited to the embodiments, and various changes can be made without departing from the gist of the present invention within the knowledge of those skilled in the art. Furthermore, the embodiments of the present invention and the features of the embodiments may be combined with each other without conflict.
Claims (7)
1. A preparation method of peptide nano-selenium is characterized by comprising the following steps:
s1, crushing selenium ore to obtain selenium ore powder;
s2, adding organic acid into the selenium ore powder, and performing electromagnetic catalytic reaction to obtain a selenium concentrated solution;
s3, taking a diluent of the selenium concentrated solution as a culture solution, and performing selenium-rich culture on the plants;
s4, extracting nutrient substances of the plants obtained in the step S3, and performing enzymolysis to obtain the peptide nano-selenium;
in step S2, the organic acid is at least one of carboxylic acid, sulfonic acid, sulfinic acid and thiocarboxylic acid;
the carboxylic acid is at least one of formic acid and acetic acid.
2. The preparation method according to claim 1, wherein in step S1, the selenium ore powder has a particle size of 60 to 80 mesh.
3. The preparation method according to claim 1, wherein in step S2, the mass ratio of the organic acid to the selenium ore powder is (2 to 50): 1.
4. the preparation method according to claim 1, wherein in the step S2, the frequency of the electromagnetic catalytic reaction is 0.3GHz to 300GHz.
5. The preparation method of claim 1, wherein in the step S2, the mass concentration of selenium in the selenium concentrated solution is 20% -45%.
6. The method according to claim 1, wherein the pH of the culture medium in step S3 is 4.5 to 6.8.
7. The method according to claim 1, wherein in step S4, the enzymatic hydrolysis is carried out using at least one enzyme selected from thiol protease and metalloproteinase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110160008.4A CN112914109B (en) | 2021-02-05 | 2021-02-05 | Preparation method and application of peptide nano-selenium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110160008.4A CN112914109B (en) | 2021-02-05 | 2021-02-05 | Preparation method and application of peptide nano-selenium |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112914109A CN112914109A (en) | 2021-06-08 |
CN112914109B true CN112914109B (en) | 2022-12-20 |
Family
ID=76170706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110160008.4A Active CN112914109B (en) | 2021-02-05 | 2021-02-05 | Preparation method and application of peptide nano-selenium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112914109B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548800A (en) * | 1982-08-02 | 1985-10-22 | Xerox Corporation | Process for selenium purification |
CN1273816A (en) * | 2000-04-28 | 2000-11-22 | 北京金山四博科技开发有限公司 | Activated and concentrated liquid containing minerals and race elements and preparing process thereof |
CN103145495A (en) * | 2013-02-27 | 2013-06-12 | 谢超 | High-energy composite peptide selenoprotein nutrient solution, preparation method and application thereof |
CN104230446A (en) * | 2014-10-21 | 2014-12-24 | 中山市巴斯德农业科技有限公司 | Preparation method for selenium-rich organic fertilizer |
CN107439120A (en) * | 2017-09-22 | 2017-12-08 | 眉山市富农水稻种植专业合作社 | A kind of implantation methods of selenium-rich orange |
CN108477376A (en) * | 2018-02-05 | 2018-09-04 | 武汉佳阳绿昶食品有限公司 | A kind of preparation method of selenium-rich and zinc-rich protein peptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106879413A (en) * | 2015-12-16 | 2017-06-23 | 无限极(中国)有限公司 | A kind of cultivation of selenium-rich blue or green money willow, extracts active ingredients and application |
-
2021
- 2021-02-05 CN CN202110160008.4A patent/CN112914109B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548800A (en) * | 1982-08-02 | 1985-10-22 | Xerox Corporation | Process for selenium purification |
CN1273816A (en) * | 2000-04-28 | 2000-11-22 | 北京金山四博科技开发有限公司 | Activated and concentrated liquid containing minerals and race elements and preparing process thereof |
CN103145495A (en) * | 2013-02-27 | 2013-06-12 | 谢超 | High-energy composite peptide selenoprotein nutrient solution, preparation method and application thereof |
CN104230446A (en) * | 2014-10-21 | 2014-12-24 | 中山市巴斯德农业科技有限公司 | Preparation method for selenium-rich organic fertilizer |
CN107439120A (en) * | 2017-09-22 | 2017-12-08 | 眉山市富农水稻种植专业合作社 | A kind of implantation methods of selenium-rich orange |
CN108477376A (en) * | 2018-02-05 | 2018-09-04 | 武汉佳阳绿昶食品有限公司 | A kind of preparation method of selenium-rich and zinc-rich protein peptides |
Also Published As
Publication number | Publication date |
---|---|
CN112914109A (en) | 2021-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102701844B (en) | Rich-selenium-germanium trace element nanometer nutrition fertilizer for vegetable and fruit soilless culture | |
CN104083468B (en) | A kind of medicine treating male oligoasthenospermia, raising sperm quality | |
KR20150143420A (en) | High-energy composite peptide selenoprotein nutrient solution, preparation method and application thereof | |
CN110257308B (en) | Method for culturing organic selenium-rich nostoc sphaeroides | |
CN103333013A (en) | Selenium-and-germanium-rich natural green environmentally-friendly ferment crop alkaline residue nutrition base fertilizer | |
KR20040071086A (en) | Cultivation of plants containing simultaneously containing germanium and selenium | |
Zhou et al. | Influence of processing methods and exogenous selenium species on the content and in vitro bioaccessibility of selenium in Pleurotus eryngii | |
Kieliszek et al. | The importance of selenium in food enrichment processes. A comprehensive review | |
CN103960531B (en) | Reduce the method for breeding of partly raising nitrogen phosphorus heavy metals emission in traditional black swine excrement scattered | |
CN108329121A (en) | A kind of fruits and vegetables Se-enriched bio-organic fertilizer and preparation method thereof | |
Adewale et al. | Toxicological significance of the occurrence of selenium in foods | |
CN112481341B (en) | Preparation method and application of selenium absorption enhancing active peptide | |
CN103435400A (en) | High-selenium-germanium cancer prevention garlic oil | |
CN112914109B (en) | Preparation method and application of peptide nano-selenium | |
CN105110990A (en) | Nutritional base fertilizer for producing selenium-germanium-enriched anticancer garlic oil | |
CN108409432A (en) | The micro- fertilizer of rich selenium germanium multielement humic acid | |
CN103704510A (en) | Scorpion feed and preparation method thereof | |
KR0135958B1 (en) | Feed and egg adding selenium-yeast | |
CN104305444B (en) | The production method of natural selenium-rich Succus Bambusae | |
WO2019024127A1 (en) | Functional mineral water and preparation method therefor | |
CN102178212A (en) | Extract of selenium-containing mushrooms | |
CN106578389A (en) | Expanded sinking feed capable of improving contents of ALA (Alanine), EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) of salmons | |
CN105565963A (en) | Fertilizer powder for culturing balancing and healthcare food corn containing natural elements | |
CN1203878C (en) | Organic state micro element supplement agent | |
KR100443131B1 (en) | Plant culture solution containing selenium and method for culturing plant using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |